The mutant of tissue-type plasminogen activator (t-PA), which contains only the Kringle-2 domain and the protease domain, has a long half-life in patients and is particularly suitable for bolus administration to treat acute myocardial infarction [24,25]. Here, PLAT is linked to acute myocardial infarction.